CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(18)30480-7
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Targeted Therapy for Breast Cancer Prevention

Frontiers in Oncology
Cancer ResearchOncology
2013English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

Breast Care
SurgeryOncology
2014English

Targeted Therapy in Gastric Cancer

European Surgery - Acta Chirurgica Austriaca
Surgery
2016English

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2010English

CXCR4-Targeted Therapy Inhibits VEGF Expression and Chondrosarcoma Angiogenesis and Metastasis

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

Bone Targeted Therapy in Breast Cancer - An Old Concept but Still Much to Do

Breast Care
SurgeryOncology
2014English

Reduced Toxicity Breast Cancer Therapy: Changing the or to and in Dual Targeted Therapeutics

2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy